Overview
Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients
Status:
Completed
Completed
Trial end date:
2010-12-01
2010-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Bausch & Lomb IncorporatedTreatments:
Bepotastine besilate
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- Subjects 12 years of age and older with 2-year history of allergic conjunctivitis
Exclusion Criteria:
- No active ocular or nasal infection